JPH0349680A - Microbacterium mutation strain 851r and preparation of 851 nutrition solution by application of said strain - Google Patents

Microbacterium mutation strain 851r and preparation of 851 nutrition solution by application of said strain

Info

Publication number
JPH0349680A
JPH0349680A JP90183854A JP18385490A JPH0349680A JP H0349680 A JPH0349680 A JP H0349680A JP 90183854 A JP90183854 A JP 90183854A JP 18385490 A JP18385490 A JP 18385490A JP H0349680 A JPH0349680 A JP H0349680A
Authority
JP
Japan
Prior art keywords
weight
strain
medium
ppm
nutrient solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP90183854A
Other languages
Japanese (ja)
Other versions
JP2613664B2 (en
Inventor
Fa Yan Zen
ゼン・フア・ヤン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPH0349680A publication Critical patent/JPH0349680A/en
Application granted granted Critical
Publication of JP2613664B2 publication Critical patent/JP2613664B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PURPOSE: To obtain a monocytic protein nutrient solution through a simple industrial fermentation process by using a specific Microbacterium mutant as productive strain by the use of a soybean powder medium or starch medium.
CONSTITUTION: This monocytic protein nutrient solution is produced by using bacteria; wherein Microbacterium mutant 851R is used as productive strain, a soybean powder medium or starch medium is used as productive medium for producing this solution through fermentation. This mutant 851R has the ability to convert a phytoprotein, esp. soybean protein, to monocytic protein. Furthermore, the mutant is a Gram-positive bacterium, nonmotile, capable of producing H2S, positive in nitrate reduction, and viable in a milk when heated at 60°C for 30 min or at 72°C for 15 min. The color of this nutrient solution becomes light at 38°C and colorless at 40°C. In particular, the DNA of the above mutant contains R-fragment which is detectable by a specific R-fragment DNA probe.
COPYRIGHT: (C)1991,JPO

Description

【発明の詳細な説明】 ために該株を産生株として使用する工業的発酵方法と栄
養溶液の製造方法とに係る。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an industrial fermentation method using the strain as a production strain and a method for producing a nutrient solution.

免iへ毘艷 今日、人体により吸収され易い単細胞タンパク質を生産
するために工業的発酵で採用可能な微生物を選択するべ
く多くの方法が試みられている。
Today, many methods are being attempted to select microorganisms that can be employed in industrial fermentation to produce single-cell proteins that are easily absorbed by the human body.

本発明者はSeに富む単細胞タンパク質とビタミンE栄
養溶液とアンモニア耐性アゾトバクターを含む細菌肥料
とを製造するための方法を公表した。
The inventors have published a method for producing a Se-rich single-cell protein and vitamin E nutrient solution and a bacterial fertilizer containing ammonia-resistant Azotobacter.

この方法は従来の工業的発酵方法によりZn,Se及び
ビタミンに富む単細胞タンパク質溶液を生産するために
、アンモニア耐性と大気窒素を使用することが可能な窒
素固定能力とを有する培養アゾトバクターを提供する. 日 の    び  ・ 本発明の目的は、株851Rを産生株として使用し、株
851Rの培養と株851Rの増殖に適切な培地の設計
φ工業的発酵方法をt’4ftすることである。
This method provides cultured Azotobacter with ammonia tolerance and nitrogen fixation capacity that allows the use of atmospheric nitrogen to produce single-cell protein solutions rich in Zn, Se and vitamins by conventional industrial fermentation methods. An object of the present invention is to use strain 851R as a production strain and design a medium suitable for culturing strain 851R and propagating strain 851R.

ダイズはタンパク質に富む食物の一種である。Soybeans are a type of protein-rich food.

することは困難である.しかしながら、株851Rの細
菌により消化後、ダイズタンパク質は単細胞タンパク質
栄養溶液に転換される.該栄養溶液は人?により容易に
消化されるタンパク質源であるのみならず、中枢神経系
を健康にし、生物の免疫増強、内分泌機能調節、老化防
止、ある種の癌細胞の増殖阻止の効果を有する一種の栄
養溶液を構成する. 本発明の微生物は微生物突然変異株851Rである。
It is difficult to do so. However, after digestion by bacteria of strain 851R, soy protein is converted into a single cell protein nutrient solution. Is the nutrient solution human? It is a kind of nutritional solution that is not only an easily digestible protein source, but also has the effect of improving the health of the central nervous system, enhancing the organism's immunity, regulating endocrine function, anti-aging, and inhibiting the growth of certain cancer cells. Configure. The microorganism of the present invention is microorganism mutant strain 851R.

この株の主特徴はグラム陽性菌であり、非運動性であり
、硝酸塩還元能力を有しており、B■Sを生成すること
が可能であり、30分間63℃又は15分間72℃に加
熱した乳汁中で生存するという点にある.その葉状体(
微生物)は赤又は橙赤色である.しかしながら、その葉
状体の色は約38℃でピンクに変わり、40℃で無色に
変わる.特に、この株のDN^は特定のRフラグメント
DN^プローブで検出可能なRフラグメントを含む。
The main characteristics of this strain are that it is a Gram-positive bacterium, is non-motile, has nitrate reducing ability, is capable of producing B■S, and can be heated to 63°C for 30 minutes or 72°C for 15 minutes. The reason is that it survives in the milk. Its thallus (
microorganisms) are red or orange-red. However, the color of the thallus turns pink at about 38°C and turns colorless at 40°C. In particular, the DN^ of this strain contains an R fragment detectable with a specific R fragment DN^ probe.

本発明は更に、単細胞タンパク質栄養溶液を生産するた
めに細菌を使用する工業的方法に係る。
The invention further relates to an industrial method of using bacteria to produce single-cell protein nutrient solutions.

この方法では、本発明で培養した微生物株851Rを産
生株として使用し、ダイズ培地又は澱粉培地を産生培地
として使用する。
In this method, the microbial strain 851R cultured according to the present invention is used as a production strain, and a soybean medium or a starch medium is used as a production medium.

物突然変異株である。主な特徴はグラム陽性の桿体であ
り、非運動性であり、グリセロールラフィノース同化能
力をもち、硝酸塩還元能力をもち、■2S生成能力をも
ち、30分間63゜C又は15分間72℃に加熱した乳
汁中で生存することである。この葉状体は赤又は橙赤色
であり、葉状体の色は38℃で薄くなり、40′Cで無
色になる.特に、株のDNAは特定のRフラグメンl−
DN^プローブで検出可能なRParklawn Dr
ive, Rockville, Marylad 2
0852に所在の^merican Type Cul
ture Collectionに^,T.C.C.寄
託番号53981で寄託されたサンプルの本質的特徴を
有する。
It is a mutant strain. The main characteristics are Gram-positive rods, non-motile, ability to assimilate glycerol raffinose, ability to reduce nitrate, ability to generate 2S, heated to 63°C for 30 minutes or 72°C for 15 minutes. It is to survive in the milk. The thallus is red or orange-red, and the color of the thallus becomes lighter at 38°C and becomes colorless at 40'C. In particular, the DNA of the strain contains a specific R fragment l-
RParklawn Dr detectable with DN^probe
ive, Rockville, Marylad 2
^merican Type Cul located at 0852
ture Collection ^, T. C. C. It has the essential characteristics of the sample deposited under deposit number 53981.

851R株は微生物属の他の種から区別される明白な特
徴を有ずる。株851Rを産生株として適用し、本発明
で設計及び使用される窒素源含有培地を適用すると、ベ
プチド、種々の微量元素及びビタミン(培養液の分析報
告中に列挙)に富む単細胞タンパク質溶液を生産するこ
とができる。培養液中には20種を越えるアミノ酸が含
まれる。この培養液100z1はアミノ酸593〜41
72B、ビタミンEO.3〜1.Owg、ビタミン80
.1〜0.3mg、ビタミンPI”0.5〜1.Ozg
、Se1.0−5.0ppm, Zn10〜20pp+
a.Mo5.0−10ppm、Co5.(1〜10pp
u+, Mn5〜15ppm及びCu3.O・〜LOp
pa+を含有する。
Strain 851R has distinct characteristics that distinguish it from other species of the microbial genus. Applying strain 851R as a production strain and applying the nitrogen source-containing medium designed and used in the present invention produces a single-cell protein solution rich in peptides, various trace elements and vitamins (listed in the culture analysis report). can do. The culture solution contains more than 20 types of amino acids. This culture solution 100z1 contains amino acids 593-41
72B, vitamin EO. 3-1. Owg, vitamin 80
.. 1-0.3 mg, vitamin PI" 0.5-1.Ozg
, Se1.0-5.0ppm, Zn10-20pp+
a. Mo5.0-10ppm, Co5. (1~10pp
u+, Mn5-15ppm and Cu3. O・〜LOp
Contains pa+.

本発明で調合及び使用される培地の重量組成を以下に示
す。
The weight composition of the medium prepared and used in the present invention is shown below.

1.ダイズ培地 ダイズ粉末          5〜10%又はダイズ
乳 〈ダイズ重量として計算)    5〜20%?は種々
の豆類ゲーキ、 ヒマワリ種子ケーキ 酵母エキス又は酵母粉末 CaCO3 K2RPO. MgSO4 NaC I Na2Mob. Na2SeO− ZnSO, CoC l■ 2.澱粉培地 澱粉を含む生材料 (サツマイモ、ジャガイモ等) 又は澱粉を含む乾燥材料 (トウモロコシ粉末等〉 酵母エキス K.HPO. 5〜10% 0.02〜0.5% 0.05〜0.5% 0、02〜0.2% 0.01〜0.08% 0.01〜O.OS% 5.0〜50ppm 1,5〜10ppm 2.5〜50ppn+ 2.5〜20ppm 10〜20% 1〜10% 0、04〜0.08% 0.05〜0.1% MgS04                 0.0
2 〜0.04%CaCOz            
      0.05〜0.5%NaCI      
             0.02〜0.04%Na
Jo04                10− 2
0pp+I1Na2SeOz            
    1.5〜20ppmZnSO42,5〜20p
p+n COC12                5〜20
ppm人体に必要な適量の他の@量元素を上記培地に加
えてもよい。元素の量は1.5〜100ppmの範囲で
ある. 株851Rの利用により栄養溶液を生産するための方法
は、撹拌器及びガストランスファーを備える慣用の槽型
発酵器で曝気培養する段階を含み、必要に応じて発酵器
は培養物を均質1ヒするために培養物を振盪するように
構戒してもよく、更に、培養期間中に細菌及び他の微生
物の酸素要求に応えるために枦過済無菌空気で培養物を
曝気するようにしてもよい.産生株として使用される8
51R株は本発明で調製される培地で増殖する。3段階
培養(第1、第2及び第3種子培養)後、その葉状体を
予め加圧滅菌した産生培地に接種し、36〜64時間イ
ンキユベートする。培養期間中、無菌空気を培地に通し
、曝気速度1:0.5〜1.Ovvm,撹拌速度180
〜260rpm、培養温度28〜4 0 ’Cとする。
1. Soybean medium Soybean powder 5-10% or soy milk (calculated as soybean weight) 5-20%? are various legumes, sunflower seed cake yeast extract or yeast powder CaCO3 K2RPO. MgSO4 NaC I Na2Mob. Na2SeO- ZnSO, CoCl 2. Starch medium Raw materials containing starch (sweet potatoes, potatoes, etc.) or dry materials containing starch (corn powder, etc.) Yeast extract K.HPO. 5-10% 0.02-0.5% 0.05-0.5% 0.02~0.2% 0.01~0.08% 0.01~O.OS% 5.0~50ppm 1.5~10ppm 2.5~50ppn+ 2.5~20ppm 10~20% 1~ 10% 0.04~0.08% 0.05~0.1% MgS04 0.0
2 ~0.04%CaCOz
0.05-0.5% NaCI
0.02-0.04% Na
Jo04 10-2
0pp+I1Na2SeOz
1.5~20ppmZnSO42,5~20p
p+n COC12 5-20
Appropriate amounts of other elements required for ppm human body may be added to the above medium. The amount of the element ranges from 1.5 to 100 ppm. The method for producing a nutrient solution utilizing strain 851R includes the step of aerating the culture in a conventional tank fermenter equipped with an agitator and gas transfer, and optionally the fermenter to homogenize the culture. Provision may be made to shake the culture for the purpose of incubation, and the culture may also be aerated with sterile air to meet the oxygen requirements of bacteria and other microorganisms during the incubation period. .. 8 used as production strain
The 51R strain grows in the medium prepared according to the present invention. After three stages of cultivation (first, second and third seed cultivation), the thallus is inoculated into a previously autoclaved production medium and incubated for 36-64 hours. During the cultivation period, sterile air was passed through the medium at an aeration rate of 1:0.5-1. Ovvm, stirring speed 180
-260 rpm and culture temperature 28-40'C.

インキュベーションの終了後、培養ブロスを加圧滅菌し
、採取する。次に、培養液を直接パッケージングして製
品とするが、種々の必要に応じ、異なる処理方法により
種々の製品が得られる。沈殿及び15000rp+I1
、圧力−0.2〜−0.4人g/cII12で遠心分N
後、培養液からコーラ型の飲料を製造することができる
。濃縮後、培養液は濃縮栄養物になる.オーブン乾燥又
はスプレー乾燥後、培養液は粉末形態となり、これを更
に処理してカプセル又はタブレットとすることもできる
.スプレー乾燥の場合、入口温度は80℃〜300℃、
出口温度は60℃〜120゜Cである.培養液を水及び
卵の代わりに小麦粉に加え、パン及びケーキ又は他の食
品を焼くことができる.培養液を化粧品の製造に使用す
ることもできる。
After the end of incubation, the culture broth is autoclaved and harvested. Next, the culture solution is directly packaged into products, and various products can be obtained by different processing methods depending on various needs. Precipitation and 15000rp+I1
, centrifugation at pressure -0.2 to -0.4 g/c II 12 N
Afterwards, a cola-type beverage can be produced from the culture solution. After concentration, the culture fluid becomes concentrated nutrients. After oven drying or spray drying, the culture liquid is in powder form, which can be further processed into capsules or tablets. For spray drying, the inlet temperature is 80℃~300℃,
The outlet temperature is 60°C to 120°C. The broth can be added to flour instead of water and eggs to bake bread and cakes or other foods. The culture solution can also be used in the production of cosmetics.

851栄養溶液は老化防止効果、体質改善、肝臓及び胃
を良好な状態に維持する効果を有する。以下、実験によ
り発明を詳細に説明する.及腹L  ゛ 体重17.8±1.75gのオスKunming産マウ
スを使用し、体重にしたがって数群に分けた.各群を1
0匹から構戒した.試験マウスに13日間連続して水道
水の代わりに851栄養溶液(851NSと省略)を与
え、14日目に絶食させた。次に、これらの試験マウス
の半数に851NSでなく水道水を与えた。試験マウス
の残りの半数には引き続き851栄養溶渣を飲用させ、
午後4時にCCI.を腹腔内投与した.対照群のマウス
には851NSでなく水道水を与え且つ14日目にバラ
フィン油(CCI.溶剤)を腹腔内投与した以外は、試
験群と同一の飼料を与えた。
851 nutritional solution has anti-aging effects, improves constitution, and maintains liver and stomach in good condition. The invention will be explained in detail through experiments below. Male Kunming mice weighing 17.8±1.75 g were used and divided into several groups according to body weight. 1 for each group
I took precautions starting from zero. Test mice were given 851 nutrient solution (abbreviated as 851NS) instead of tap water for 13 consecutive days and fasted on the 14th day. Half of these test mice were then given tap water instead of 851NS. The other half of the test mice continued to drink the 851 nutrient solution.
CCI. at 4 p.m. was administered intraperitoneally. The mice in the control group were fed the same diet as the test group, except that they received tap water instead of 851NS and intraperitoneal administration of paraffin oil (CCI.solvent) on the 14th day.

CC.4対照群のマウスに同一飼料を与え且つ水道水を
飲用させた。それらの動物を絶食させ、午後にCCI<
(1.87mmol/AIF)を腹腔内投与した。
C.C. Four control groups of mice were fed the same diet and allowed to drink tap water. The animals were fasted and the CCI<
(1.87 mmol/AIF) was administered intraperitoneally.

15日目に動物を殺し、肝臓サンプルを調製した.Ri
roshi Ohakawa(旧roshi Obak
awa et at、^nal.Biocl+em. 
95 :351−358. 1979)の方法にしたが
って肝臓のM[)八を検出し、1,1,3.3−テトラ
メ1−キシプロパン〈日本TCI製品、E.P.グレー
ド)を過酸化脂質の検出用標準サンプルとして使用し、
スペクト口フォトメーターを使用して80^の吸光度を
検出した。MD^含有量を肝TiAg当たりnmo I
として表す.データを統計的に分析した.結果は次の通
りであった。
Animals were sacrificed on day 15 and liver samples were prepared. Ri
roshi Ohakawa (formerly roshi Obak)
Awa et at, ^nal. Biocl+em.
95:351-358. M[)8 in the liver was detected according to the method of 1979), and 1,1,3,3-tetrameth-1-xypropane (Japan TCI product, E. P. grade) was used as a standard sample for detection of lipid peroxide,
Absorbance at 80^ was detected using a spectrophotometer. MD^ content as nmo I per liver TiAg
Expressed as The data were analyzed statistically. The results were as follows.

この結果、851栄簑溶液は所定の条件で老化防止に有
用な強い抗過酸化脂質活性を有することが判明した. 丸艷2L麹L監 体重15〜249のオスKuna+ing産マウスを使
用し、数群に分けた.マウスに水、チョウセンニンジン
、Nestle粉ミルク及び851NSを夫々与えた。
As a result, it was found that 851 Eikan solution has strong anti-peroxidant lipid activity that is useful for anti-aging under certain conditions. Male Kuna+ing mice with a weight of 15 to 249 were used and divided into several groups. Mice were given water, ginseng, Nestle powdered milk and 851NS, respectively.

851NS群のマウスは水道水の代わりに851NS(
5〜fhll日)を4日間与えた. 対照群のマウスには水道水を4日間与えた。
Mice in the 851NS group received 851NS (
5 to fhll days) for 4 days. Mice in the control group were given tap water for 4 days.

Nestle粉ミルク群のマウスには水道水の代わりに
0、Ol%Nestle粉ミルクを4日間与えた。
Mice in the Nestle powdered milk group were given 0.01% Nestle powdered milk instead of tap water for 4 days.

天然のチョウセンニンジンをスライス状に細分し、沸騰
水に約3時間浸漬し、その後、弱く加熱しながら15分
間に2回沸騰させて濃度0.001%とし、これを水道
水の代わりにマウスに4日間与えた。
Cut natural Korean ginseng into slices, soak in boiling water for about 3 hours, then boil twice for 15 minutes while heating gently to give a concentration of 0.001%, and use this as a substitute for tap water for mice. I gave it for 4 days.

WaB  Yun−muo(Journal  or 
 Shanghai  Medicine  2:46
−48. 1985)の方法に従って遊泳試験を実施し
た。
WaB Yun-muo (Journal or
Shanghai Medicine 2:46
-48. A swimming test was conducted according to the method of (1985).

結果を以下に示す。The results are shown below.

この結果、851栄養溶液はマウスの遊泳時間を大幅に
延ばし、マウスの体格を改善することが判明した。
As a result, it was found that the 851 nutrient solution significantly extended the swimming time of mice and improved the physique of mice.

X量』ユ”   FCCに る 使用済み培養液の廃棄後、良好な繁殖状態の胃癌細胞(
FCC)を0,02%EDT^で消化し、15%ウシ血
清を含有する1640培地で洗浄した.生存細胞をトリ
プトファンブルーで計数し、総容量1i+l(I X 
10’/l1)中で37℃で24時間培養した.次に細
胞を洗浄し、851NS(0.2zffi/i1)を含
有する同一培地で培養した。対照群の細胞を容量1zf
fiの培地(15%ウシ血清を含有する1640培地1
ose及び851NS2zi’)で37℃で24時間培
養した。各群のウェルは2つずつ用意した.次に、使用
済み培地を廃棄した。0.02%EOTAQ.!IfR
1及び1・リプ1・ファンブル一〇.Li&を加え、生
存細胞を計数した。
After disposing of the used culture medium at the FCC, gastric cancer cells in a good breeding state (
FCC) was digested with 0.02% EDT^ and washed with 1640 medium containing 15% bovine serum. Viable cells were counted with tryptophan blue and total volume 1i+l (I
10'/l1) at 37°C for 24 hours. Cells were then washed and cultured in the same medium containing 851NS (0.2zffi/i1). control group cells to a volume of 1zf
fi medium (1640 medium containing 15% bovine serum 1
ose and 851NS2zi') at 37°C for 24 hours. Two wells were prepared for each group. The spent medium was then discarded. 0.02% EOTAQ. ! IfR
1 and 1・Reply 1・Fumble 10. Li& was added and viable cells were counted.

抑制率=し二一×100% l1 ?及びn2は夫々対照群及び試験群における生存細胞の
数である。
Suppression rate = Shi21 x 100% l1? and n2 are the number of viable cells in the control group and test group, respectively.

この結果、胃癌細胞に対する851NSの平均抑制率は
30%であることが判明した。
As a result, it was found that the average inhibition rate of 851NS against gastric cancer cells was 30%.

1■Euloteserassusに Euplotes crassusは海水中で生存する
単細胞生物である.細胞齢は無性生殖世代により表され
、1000〜1500の範囲である. Euplotes crassusi胞の老化はある種
の代謝変化に関係する.これらの変化のうちで細胞分裂
速度の低下は細胞老化の最も顕著な特徴のひとつである
.10%の851NSを含有する海水中で細胞を培養す
ると、Euplotes crassus細胞の分裂速
度は著しく増加した.培養期間中の5日間の細胞分裂速
度(世代7日)を以下に示す。
1. Euloteserassus Euplotes crassus is a unicellular organism that lives in seawater. Cell age is expressed by asexual generations and ranges from 1000 to 1500. Aging of Euplotes crassusi cells is associated with certain metabolic changes. Among these changes, a decrease in the rate of cell division is one of the most prominent features of cellular aging. The division rate of Euplotes crassus cells was significantly increased when the cells were cultured in seawater containing 10% 851NS. The cell division rate for 5 days during the culture period (7 days of generation) is shown below.

上表から明らかなように、Euplotes cras
sus[胞の分裂速度は海水培地が10%の851NS
を含有するとき1.l1〜l.67倍増加した.851
NSを細胞に食菌すると細胞代謝は改善された. 培地が10%の851栄養溶液を含有するとき、老化し
たEuplotes crassus細胞(Zoo世代
齢〉の分裂速度は1.4倍(0.33〜0.79世代/
日)増加した.この結果、851栄養溶液は老化した細
胞の代謝を改善できることが判明した. 1,材料: 1(unming産マウスをFujian Medic
al Collegeの動物センターから入手した。8
51栄養溶液のバッチ番号は06である。
As is clear from the table above, Euplotes cras
sus [The cell division rate is 851NS with a seawater medium of 10%.
When containing 1. l1-l. It increased by 67 times. 851
When NS was phagocytosed into cells, cell metabolism was improved. When the medium contains 10% 851 nutrient solution, the division rate of aged Euplotes crassus cells (Zoo generation age) is 1.4 times (0.33-0.79 generations/
day) increased. The results showed that 851 nutrient solution can improve the metabolism of aging cells. 1. Materials: 1.
al College of Animal Center. 8
The batch number for the 51 nutrient solution is 06.

2,方法: I2匹の妊娠中のKunming産マウスに標準飼料及
び水道水を別々に与えた。分娩後、12匹のマウスを対
照群と851NS群とにランダムに分けた。吸乳時に同
産(同じ親から産まれた)の新生マウスを計量した。対
照及び851NS群の母親及び新生マウスに吸乳期間中
及び離乳がら15日後に夫々標準飼料又は851NSを
含有する飼料を与えた.次に、同産の新生マウスを計量
した。新生マウスの眼球がら証液サンプルを採取した。
2. Method: I Two pregnant Kunming mice were fed standard chow and tap water separately. After parturition, 12 mice were randomly divided into control group and 851NS group. Newborn mice from the same litter (born from the same parents) were weighed at the time of suckling. Mothers and newborn mice of the control and 851NS groups were fed standard feed or feed containing 851NS during the suckling period and 15 days after weaning, respectively. Next, newborn mice from the same litter were weighed. Fluid samples from the eyeballs of newborn mice were collected.

新生マウスの体重増加 及び白血球分類は次の通りであった. 級1己Lv』]乙 l.結果: 1.1 第1表は新生マウスの体重変化を示す.1.2 第2表は新生マウスの白血球分化に及ぼす851NSの
効果を示す. Δ2衆:妓a圭ll■ 2.考察 851栄養溶液は20種を越えるアミノ酸、数種のビタ
ミン及び微量元素を含有する生物工学産物であった。結
果から明らかなように、851栄養溶液は新生マウスの
リンパ球の値を著しく増加させ、従って、851NSは
新生マウスの造血機能を刺激及び改善し得ることが判明
した。
The weight gain and white blood cell classification of newborn mice were as follows. Class 1 Self Lv'] Otsu l. Results: 1.1 Table 1 shows the changes in body weight of newborn mice. 1.2 Table 2 shows the effect of 851NS on leukocyte differentiation in newborn mice. Δ2 group: Gisa Keill ■ 2. Discussion 851 nutrient solution was a bioengineered product containing over 20 amino acids, several vitamins, and trace elements. As is evident from the results, 851 nutritional solution significantly increased the level of lymphocytes in newborn mice, thus it was found that 851NS could stimulate and improve the hematopoietic function of newborn mice.

更に結果として、85R4Sは新生マウスの体重を増加
することができ、851NSは新生マウスの発育を増進
する成分を含むことが判明した。
Furthermore, the results revealed that 85R4S can increase the weight of newborn mice, and 851NS contains components that promote the growth of newborn mice.

4艷L マウスの   の     に  る?セ住■
舶R1L 1.材料 体重42〜44gのuI雄のKunming産マウスを
FujianMedical Collegeの動物セ
ンターから入手した。
Do you want to go to the bottom of the 4th L mouse? Se-ju ■
Vessel R1L 1. Materials: uI male Kunming mice weighing 42-44 g were obtained from the animal center of Fujian Medical College.

851NS、4N IC+及び0.1%インドメタシン
を使用した. 2.方法 2.1マウスの胃粘膜の亜慢性損傷モデルの作成8匹の
マウスをランダムに2群に分けた.対照群のマウスには
正規食塩水を1日1回経口投与した.試験群のマウスに
は48 HCI又は0.1%インドメタシンを交互にl
日1回2日間(経口)投与した.これらのマウスに通常
の飼料及び水道水を与えた.10日後、マウスを殺した
.胃を取り出し、水洗した,対照群の胃粘膜はつやのあ
る赤色を示したが、試験群の胃粘膜はつやがなく、色が
薄く、膨張していた.胃腔に固定用の10%中性ホルマ
リンを充填し、バラフィンワックスでセクションに分け
、IIE染色で染色した。胃粘膜を顕微鏡で検査した処
、粘膜の内皮は薄くなり、腐食したケラチン物質で覆わ
れ、胃腺には腐食した壊死が敗在していることが判明し
た.対照群には顕著な変化は認められなかった.上記方
法は亜慢性損傷のモデルとなり得ることが確認された。
851NS, 4N IC+ and 0.1% indomethacin were used. 2. Method 2.1 Creation of subchronic injury model of gastric mucosa in mice Eight mice were randomly divided into two groups. Normal saline was orally administered to mice in the control group once a day. Mice in the test group received alternating doses of 48 HCI or 0.1% indomethacin.
The drug was administered (orally) once a day for 2 days. These mice were fed regular chow and tap water. After 10 days, the mice were sacrificed. The stomachs were removed and washed with water. The gastric mucosa of the control group showed a shiny red color, but the gastric mucosa of the test group was dull, pale, and swollen. The gastric cavity was filled with 10% neutral formalin for fixation, divided into sections with paraffin wax, and stained with IIE staining. Microscopic examination of the gastric mucosa revealed that the endothelium of the mucosa was thinned and covered with corroded keratinous material, and the gastric glands were colonized with corroded necrosis. No significant changes were observed in the control group. It was confirmed that the above method can serve as a model for subchronic injury.

2、2マウスの胃粘膜の亜慢性損傷に対する851NS
の治療効果 30匹のマウスを対照群と851群とにランダムに分け
、上記方法に従ってHCI又はインドメタシンを交互に
10日間投与した.これらの2群のマウスに夫々標準飼
料又は851を含有するIIIril料を10口間与え
、HCI又はインドメタシンの投与を停止してからも7
日間飼料を与え続けた.次にマウスを殺した。上記方法
に従って胃粘膜の変化を試験した。
2,2 851NS against subchronic injury of gastric mucosa in mice
Therapeutic effect of 30 mice were randomly divided into control group and 851 group, and HCI or indomethacin was administered alternately for 10 days according to the above method. These two groups of mice were given standard chow or IIIril food containing 851 for 10 sips, and even after the administration of HCI or indomethacin was stopped, the
Feed was continued for days. Then the mice were killed. Changes in gastric mucosa were tested according to the above method.

髭匙えL1色 対照及び851群の間の胃粘膜の形態に顕著な差異は認
められなかった.851群の胃の前部の粘膜は対照群よ
りもやや薄かった.結果として、851は胃粘膜の損傷
の回復に有益であることが判明した。
No significant difference was observed in the morphology of the gastric mucosa between the Hige-sai L1 color control and 851 groups. The anterior stomach mucosa of the 851 group was slightly thinner than that of the control group. As a result, 851 was found to be beneficial in the recovery of gastric mucosal damage.

1.方法 ラットを対照及び851群にランダムに分け、夫々標準
飼料及び851を含有する飼料(8i+ffi/ラット
)を与えた。全ラットに十分な水道水を与え.15日後
、全ラットを14日間絶食させ、1日1回の割合で2日
間インドメタシン(2.5i+y/ラット)を皮下投与
した.2回目の注射から18時間後、ラットを殺し、胃
を試験した。
1. Method Rats were randomly divided into control and 851 groups and fed standard chow and chow containing 851 (8i+ffi/rat), respectively. Provide all rats with sufficient tap water. After 15 days, all rats were fasted for 14 days and indomethacin (2.5i+y/rat) was subcutaneously administered once a day for 2 days. Eighteen hours after the second injection, the rats were sacrificed and the stomachs were examined.

症え丈L{炙 l.結果 胃粘膜の急性出血の数及び程度:対照群では6匹のマウ
ス、851群では4匹の′マウスの胃粘膜の出血が斑状
、縞状又は伸長状態で局所的に制限された。対照群の1
匹のラットに胃粘膜の拡散出血が発生した。胃粘膜の出
血点の株は対照群で6〜l2カ所、851群で2〜8カ
所であった.対照群の胃粘膜の出血の数は851群より
も著しく多数であった。
Symptom length L {roasted l. Results Number and extent of acute bleeding in the gastric mucosa: The bleeding in the gastric mucosa of 6 mice in the control group and 4 mice in the 851 group was locally limited in a patchy, striped or elongated state. Control group 1
Diffuse hemorrhage of the gastric mucosa occurred in one rat. The number of bleeding points on the gastric mucosa was 6 to 12 in the control group and 2 to 8 in the 851 group. The number of gastric mucosal hemorrhages in the control group was significantly higher than in the 851 group.

2.考察 結果から明らかなように、インドメタシンで誘導した胃
粘膜の出血はラッ1・に85INSを15日間与えた場
合に阻止された。
2. As is clear from the results, gastric mucosal bleeding induced by indomethacin was prevented when rats were given 85INS for 15 days.

1.材料 体重140 〜22hのl’listar産ラット22
匹(オス10匹及びメスl2匹)をFujian Me
dical Collegeの動物センターから入手し
た.CCI.分析グレードは精製落花生油で濃度40%
に希釈した, 851NS、寒天ゲル(Shangha
i Che+sical Agent !4anufa
ctoryの製品〉及びLEB多用途電気泳動装置を使
用した.2.方法 22匹のラットをランダムに対照群(n=6)、CCI
.群(ii=8)及びCCI4+851群(ロー8)の
3群に分けた.CCI.及びCCl.+851群のラッ
トにはCCl.(0.1瀧U100g)を1週間に2回
(3日おき)の割合で5週間皮下投与した.対照及びC
CI.群のラットには標準飼料を与えた.CCI,+8
51群のラットには851NSを含有する飼料(8zU
ラット.7日)を与えた.全ラットに5週間十分な水道
水及び飼料を与えた, CCl4の最終投与から5日後
に、腋窩静脈から血液を採取した,血清を集め、肝機能
を検出した, LEB電気泳動装置を使用して血清タン
パク質の電気泳動を実施した.肝臓の病理変化を試験し
た. 艶4LL1東 1.結果: 1.1ラットSGPT CCI.で したラットのSGI’T亦 に ぼ 851NS 京p1は対照群に比較、p2はCCI.群に比較.1.
2これらの群の間でチモール濁り試験(TTT)及び硫
酸亜鉛濁り試@(ZnTT)に顕著な差異は認められな
かった. 1.3肉眼による肝臓観察:対照群の肝臓嚢の色及びつ
やは正常であった.肝臓嚢はつやがあった.CCI.群
のラットの肝臓嚢は水様変性(waterydegen
eration)をけう肝臓の形態変化に従い薄茶色で
つやがなかった.CCI.+851群のラットの肝臓形
態はCCI.群よりも良好であったが、対照群よりは劣
った。
1. 22 l'listar rats weighing 140-22h
Fujian Me (10 males and 2 females)
Obtained from animal center of dical college. CCI. The analytical grade is refined peanut oil with a concentration of 40%.
851NS diluted in agar gel (Shangha
i Che+sical Agent! 4anufa
ctory products> and LEB versatile electrophoresis equipment. 2. Method 22 rats were randomly assigned to control group (n=6), CCI
.. The patients were divided into three groups: group (ii=8) and CCI4+851 group (low 8). CCI. and CCl. Rats in the +851 group received CCl. (100 g of 0.1 taki U) was administered subcutaneously twice a week (every 3 days) for 5 weeks. Control and C
C.I. The rats in the group were fed standard chow. CCI, +8
Group 51 rats were fed a diet containing 851NS (8zU
Rat. 7 days). All rats were provided with sufficient tap water and food for 5 weeks; 5 days after the final administration of CCl, blood was collected from the axillary vein; serum was collected and liver function was detected; using an LEB electrophoresis device. Electrophoresis of serum proteins was performed. Pathological changes in the liver were examined. Aya 4LL1 East 1. Results: 1.1 Rat SGPT CCI. Rat SGI'T and 851NS Kyo p1 was compared to the control group, p2 was CCI. Compare to groups. 1.
2 No significant differences were observed in the thymol turbidity test (TTT) and zinc sulfate turbidity test @ (ZnTT) between these groups. 1.3 Visual observation of the liver: The color and gloss of the liver sac in the control group were normal. The liver sac was shiny. CCI. The liver sacs of rats in the group showed watery degeneration.
The color of the liver was light brown and lackluster, in accordance with the morphological changes of the liver due to aging. CCI. The liver morphology of rats in the +851 group was CCI. It was better than the control group, but worse than the control group.

1.4顕微鏡による肝臓観察:対照群では弱い水様変性
を示す1匹を除く5匹のラットの肝臓組,*i造は正常
であった, CCI.群の8匹のラットは顕著な肝臓水
様変性を示した.肝小葉の外側部分の血漿は拡散又は集
中した網状アレオシス(areosis)を示した.肝
小葉の中心部分の細胞は正常なものと変性したものがあ
った.脂肪変性した肝細胞は散在又は集中しており、水
様変性細胞から区別することは困難であった.CCl.
+851群の6匹のラットの肝臓はCCI.群のラット
よりも水様変性が少なく、他の2匹のラットはCCI.
群と同一程度の水様変性を示した。ラットの肝臓組織変
化は肝機能S(;PTの結果に従った。これは全群のラ
ットSGI’Tの結果が信頼できることを意味する。
1.4 Liver observation under a microscope: In the control group, the liver structure of five rats except one with weak watery degeneration was normal, CCI. Eight rats in the group showed significant hepatic watery degeneration. Plasma in the lateral parts of the liver lobules showed diffuse or focal reticular areosis. There were normal cells and degenerated cells in the central part of the liver lobules. The steatotic hepatocytes were scattered or concentrated, and it was difficult to distinguish them from the watery degenerated cells. CCl.
The livers of 6 rats in the +851 group were treated with CCI. The other two rats had less watery degeneration than the rats in the CCI.
It showed the same degree of watery degeneration as the group. The liver histological changes in rats followed the results of liver function S(;PT. This means that the results of rat SGI'T in all groups were reliable.

1.5ラット血清タンパク質の電気泳動:各群から2つ
の血清サンプルを電気泳動に使用した.結果はこれらの
群に差異がないことを示した.これらの結果から、CC
I.で誘導した肝臓損傷はラットの血清タンパク質に変
化をもたらさないことが判明した。
1.5 Electrophoresis of rat serum proteins: Two serum samples from each group were used for electrophoresis. The results showed that there were no differences between these groups. From these results, CC
I. It was found that the liver injury induced by 20% did not result in changes in serum proteins in rats.

1、6体重増加: CCl.+851群のラットの体重
増加は他の群よりも大きかったが、これらの群の間に統
計的に顕著な差異は認められなかった(p>0.05)
 . 2.考察 肉眼及び顕微鏡によりラット血清SGPT及び形態変化
を検査した結果、85lはCCI,で誘導した亜慢性肝
臓損傷に対して予防及び治療効果を示すことが判明した
. 1.材料 Kunming産マウスをFujian動物センターか
ら入手した. を使用した. Medical Collegeの 851NS(バッチ番号06) 2.方法 同一種のオスマウスと交尾させ、予め妊娠していると見
なされる(膣血栓を有する)Kunming産メスマウ
ス27匹を対照群及び851群にランダムに分けた.対
照群のマウスには標準飼料を与え、851群のマウスに
は851を含有する飼料を与えた.全マウスに水道水を
与えた.7匹のマウスを各群がらランダムに抽出し、腹
部の肥大がら妊娠していること、を確認後、上記方法に
より別々に飼料を与えた.同産の新生マウスを出産日及
び20日間吸乳後に計量した.新生及び吸乳中のマウス
の体重及び外観を検査した. 級五R914  . l.結果 1 .R 1新生マウス(出産直後)の体重に及ぼす8
51NSの効果 3表:新生マウスの体重に ぼ lの効果 本対照群と比較. 1.2 吸乳期のマウスの体重に及ぼす851NSの効果を第4
表に示す。
1,6 Weight gain: CCl. Although the weight gain of rats in the +851 group was greater than that of other groups, there were no statistically significant differences between these groups (p>0.05)
.. 2. Discussion As a result of visually and microscopically examining rat serum SGPT and morphological changes, it was found that 85l exhibited preventive and therapeutic effects on CCI-induced subchronic liver damage. 1. Materials Kunming mice were obtained from Fujian Animal Center. It was used. 851NS of Medical College (batch number 06) 2. Method: Twenty-seven Kunming female mice, which were mated with male mice of the same species and considered to be pre-pregnant (with vaginal thrombus), were randomly divided into a control group and an 851 group. Mice in the control group were fed standard chow, and mice in the 851 group were fed chow containing 851. All mice were given tap water. Seven mice were randomly selected from each group, and after confirming that they were pregnant due to enlarged abdomens, they were fed separately using the method described above. Newborn mice from the same litter were weighed on the day of birth and after suckling for 20 days. The weight and appearance of newborn and suckling mice were examined. Class 5 R914. l. Result 1. Effect of R1 on the body weight of newborn mice (immediately after birth)
Effects of 51NS Table 3: Effects of BoI on the body weight of newborn mice compared with the main control group. 1.2 The effect of 851NS on the body weight of mice during the suckling period
Shown in the table.

1.3外観、食事能力及び一般活動に異常な現象は践察
されなかった. 2.考察 2.1第3表から明らかなように、メスマウスに妊娠期
間中に851NSを与えると851NSはマウス胎児の
体重増加を促進することができた(p< 0.01)。
1.3 No abnormalities were observed in appearance, eating ability, or general activity. 2. Discussion 2.1 As is clear from Table 3, when 851NS was given to female mice during pregnancy, 851NS was able to promote weight gain in mouse fetuses (p<0.01).

2.2第4表から明らかなように、メスマウスに授乳期
間中に851NSを与えると851NSは吸乳中のマウ
スの体重増加を促進することができた<p< 0.05
)。
2.2 As is clear from Table 4, when 851NS was given to female mice during the lactation period, 851NS was able to promote the weight gain of the suckling mice <p<0.05
).

2.3結果から明らかなように、メスマウスに妊娠から
授乳まで40日間851NSを与えたとき、異常発生(
例えば胎児奇形〉及び逆効果は観察されながった. 以下、本発明の実施例を非限定的に説明する.及東燵L この調製には2.5t容の槽形発酵器を使用した。
2.3 As is clear from the results, when female mice were given 851NS for 40 days from pregnancy to lactation, abnormalities occurred (
For example, no fetal malformations or adverse effects were observed. Examples of the present invention will be described below in a non-limiting manner. Oito-tsuru L A 2.5 t capacity tank fermenter was used for this preparation.

種子発酵器は0.5t容とした。粗材料の装入量は40
%であり、ダイズ粉末5%、酵母エキス0.04%、K
ll2P0. 0.05%、MgSO. 0.02%、
CaCOs 0.02%、NaCl O.02%、Na
2MoOi 10ppm、Na2SeO. 2.5 p
p(ZnSO. 10ppm、CoCl22.5ppm
及び水を含有する産生培地として5%ダイズ培地を採用
した。接種材料の量は1%であり、種子発酵器は21、
細胞齢は24時間(第1種子培養一第2種子培養一第3
種子培養、24時間インキユベートした培養物を接種材
料として使用)、培養温度は30℃とし、撹拌速度26
0rpse、曝気速度1:0.aVV鴎とした.培養物
のインキュベーションは45時間持続した.インキュベ
ーションの終了後、培養物を加圧滅菌し、アセンブリラ
インを通してびんに詰め、その後、再び加圧滅菌して最
終製品とした. 培養液100z1は乾燥材 料3.7%、 タンパク質2.06%、 脂質0.23%、 炭水 化物 0.75%、 ビタミン及び無機塩を含有していた(第5表). この調製には8t容の槽形発酵器を使用した。粗材料の
装入量は40%とした.すなわち、培地の量を3.2t
とした.10%ダイズ乳を採用した。培地はダイズ32
0&,、酵母エキス1 .28k9、κH2PO. i
.e.fI、?8SO4 640y− CaCOs  
640g、NaCI  6401I,  NI12MO
04321F, NazSeO* 8g、ZnSO+ 
32y、CoCl■8g及び水を含有するものとした.
接種材料の量は1%、細胞齢は24時間(第1種子培養
、第2種子培養及び第3種子培養、24時間インキユベ
ートした培養物を接種材料として使用)とした.培養温
度30゜C.撹拌速度220rpm、曝気速度1 :0
.8vvmとした.種子発酵器でインキュベーションの
終了後、接種材料を81容槽形発酵器に接種し、培養温
度30℃、撹拌速度22Grp論、曝気速度1:0.8
vvmとした。48時間後にインキュベーションを終了
し、培養液を加圧滅菌し、アセンブリラインを通してび
んに詰め、再び加圧滅菌して最終製品を得た。培養液1
00jfは、アスパラキン酸543mg、グル9 ミン
vi710mg、セリン160B、グリシン280mg
、ヒスチジン65mg、アルギニン226u、スレオニ
ン232JllF、アラニン359ig、ブロリン12
6+B、チロシン10fB、バリン283i+g、メチ
オニン53旬、イソロイシン262B、ロイシン309
1Il?、フェニルアラニン148JIIF、リジン2
12B、シスチン38瀧9、合計4172zgを含有し
ていた。
The seed fermenter had a capacity of 0.5 t. The raw material charge is 40
%, soybean powder 5%, yeast extract 0.04%, K
ll2P0. 0.05%, MgSO. 0.02%,
CaCOs 0.02%, NaClO. 02%, Na
2MoOi 10ppm, Na2SeO. 2.5p
p(ZnSO. 10ppm, CoCl22.5ppm
A 5% soybean medium was used as a production medium containing water and water. The amount of inoculum is 1%, the seed fermenter is 21,
Cell age is 24 hours (1st seed culture - 2nd seed culture - 3rd seed culture)
Seed culture, culture incubated for 24 hours was used as inoculum), culture temperature was 30 °C, stirring speed was 26
0rpse, aeration rate 1:0. It was called aVV seagull. Incubation of the culture lasted 45 hours. After incubation, the culture was autoclaved, passed through an assembly line into bottles, and then autoclaved again to give the final product. Culture solution 100z1 contained 3.7% dry material, 2.06% protein, 0.23% lipid, 0.75% carbohydrate, vitamins and inorganic salts (Table 5). An 8 ton tank fermenter was used for this preparation. The amount of raw material charged was 40%. In other words, the amount of medium was 3.2t.
It was. 10% soy milk was used. Medium is soybean 32
0 &, yeast extract 1. 28k9, κH2PO. i
.. e. fI,? 8SO4 640y- CaCOs
640g, NaCI 6401I, NI12MO
04321F, NazSeO* 8g, ZnSO+
32y, 8g of CoCl and water.
The amount of inoculum was 1%, and the cell age was 24 hours (first seed culture, second seed culture, and third seed culture; cultures incubated for 24 hours were used as inoculum). Culture temperature 30°C. Stirring speed 220 rpm, aeration rate 1:0
.. It was set to 8vvm. After incubation in the seed fermenter, the inoculum was inoculated into an 81-container fermenter, and the culture temperature was 30°C, the stirring rate was 22Grp, and the aeration rate was 1:0.8.
vvm. After 48 hours, the incubation was terminated, and the culture solution was autoclaved, passed through an assembly line, bottled, and autoclaved again to obtain the final product. Culture solution 1
00jf is asparachynic acid 543mg, glu9mine vi710mg, serine 160B, glycine 280mg
, histidine 65mg, arginine 226u, threonine 232JllF, alanine 359ig, broline 12
6+B, tyrosine 10fB, valine 283i+g, methionine 53, isoleucine 262B, leucine 309
1Il? , phenylalanine 148JIIF, lysine 2
It contained 12B, cystine 38 and 9, totaling 4172 zg.

及東鰹よ 実施例2に記載した方法により調製した栄養溶液を、乾
燥ミルクの製造に通常使用されているスプレードライヤ
ーにより乾燥し、851栄養粉末を得た.スプレードラ
イヤーの入口温度は80゜C、出口温度は60℃とした
。851栄養溶液0.81から乾燥粉末20.4AFI
を得、これを更に処理してカプセル状にした.カプセル
1包は乾燥粉末0.28gを含み、又は澱粉80A,及
び蜂蜜10A9とから調合して顆粒調製物とした. X韮』しk 慣用の発酵方法により調製した851栄養溶液を150
0orpmで遠心分離し、沈殿を得た。こうして、85
1栄養溶液1tから上清960kgを得た。果汁500
&gを加えることにより851果汁コーラを調製し、蜂
蜜40kgを加えることにより851蜂蜜コーラを調製
した.上記上清に香味料を加え、必要に応じて異なる味
の種々の851飲料を調製することもできる。
The nutrient solution prepared by the method described in Example 2 from Oito Bonito was dried using a spray dryer commonly used in the production of dried milk to obtain 851 nutrient powder. The inlet temperature of the spray dryer was 80°C, and the outlet temperature was 60°C. 851 Nutrient Solution 0.81 to Dry Powder 20.4 AFI
This was further processed and made into capsules. One capsule contained 0.28 g of dry powder, or was formulated into a granule preparation with 80A starch and 10A9 honey. 851 nutrient solution prepared by conventional fermentation method to 150
Centrifugation was performed at 0 rpm to obtain a precipitate. Thus, 85
960 kg of supernatant was obtained from 1 ton of nutrient solution. fruit juice 500
851 fruit juice cola was prepared by adding &g, and 851 honey cola was prepared by adding 40 kg of honey. Flavoring agents can also be added to the supernatant to prepare various 851 beverages with different tastes as desired.

l隨燵i 慣用の発酵方法により調製した851栄養溶液を遠心分
離した.上清を膜蒸発器又は真空回転蒸発器により濃縮
し、851濃縮栄養物を得た。蒸発後、上清0.5Lか
ら濃縮栄養物100A9を得た.蜂蜜toe,,を添加
後、濃縮栄養物を開放容易なキャップを有する小びんに
充填した。この栄養物は経口摂取するのに都合よい.
851 Nutrient solution prepared by conventional fermentation methods was centrifuged. The supernatant was concentrated by membrane evaporator or vacuum rotary evaporator to obtain 851 concentrated nutrients. After evaporation, concentrated nutrients 100A9 were obtained from 0.5 L of supernatant. After adding the honey toe, the concentrated nutrients were filled into vials with easy-open caps. This nutrient is convenient to take orally.

Claims (9)

【特許請求の範囲】[Claims] (1)植物タンパク質、特にダイズタンパク質を単細胞
タンパク質に転換する能力を有しており、グラム陽性菌
であり、非運動性であり、H_2Sを生成することが可
能であり、硝酸塩還元陽性であり、30分間60℃又は
15分間72℃に加熱時に乳汁中で生存し、赤又は橙赤
色の葉状体であり、該葉状体の色が38℃でピンクに変
わり、40℃で無色に変わり、株のDNAが特定のRフ
ラグメントDNAプローブにより検出可能なRフラグメ
ントを含む特徴を有するマイクロバクテリウム突然変異
株851R。
(1) It has the ability to convert plant proteins, especially soybean proteins, into single-cell proteins, is a Gram-positive bacterium, is non-motile, is capable of producing H_2S, and is nitrate reduction positive; It survives in milk when heated to 60°C for 30 minutes or 72°C for 15 minutes, has red or orange-red thallus, and the color of the thallus changes to pink at 38°C and colorless at 40°C, indicating that the strain Microbacterium mutant strain 851R whose DNA is characterized by containing an R fragment detectable by a specific R fragment DNA probe.
(2)米国、12301 Parklawn Driv
e,Rockville,Marylad 20852
に所在のAmerican Type Culture
CollectionにA.T.C.C.寄託番号53
981で寄託されたサンプルの本質的特徴を有するマイ
クロバクテリウム突然変異株851R。
(2) 12301 Parklawn Drive, USA
e, Rockville, Marylad 20852
American Type Culture located in
Collection includes A. T. C. C. Deposit number 53
Microbacterium mutant strain 851R having essential characteristics of the sample deposited in 981.
(3)細菌を使用することにより単細胞タンパク質栄養
溶液を製造するための方法であって、産生株としてマイ
クロバクテリウム突然変異株851Rを使用し、発酵に
より851R栄養溶液を生産するための産生培地として
ダイズ粉末培地又は澱粉培地を使用することを特徴とす
る方法。
(3) A method for producing a single-cell protein nutrient solution by using bacteria, using Microbacterium mutant strain 851R as a production strain and as a production medium for producing 851R nutrient solution by fermentation. A method characterized by using a soybean powder medium or a starch medium.
(4)培養液から単細胞タンパク質を採取するためにオ
ーブン乾燥噴霧処理を使用し、培養液を精製するために
濃縮処理を使用することを特徴とする請求項3に記載の
方法。
(4) The method according to claim 3, characterized in that an oven-drying spray process is used to collect single cell proteins from the culture solution, and a concentration process is used to purify the culture solution.
(5)ダイズ粉末5〜10重量%又はダイズ乳(ダイズ
重量として計算)5〜20重量%又は種々の豆類ケーキ
、ヒマワリ種子ケーキ5〜10重量%、酵母エキス又は
酵母粉末0.02〜0.5重量%、CaCO_30.0
5〜0.5重量%、K_2HPO_40.02〜0.2
重量%、MgSO_40.01〜0.08重量%、Na
Cl0.01〜0.08重量%、Na_2MoO_45
〜50重量ppm、Na_2SeO_31.5〜10重
量ppm、ZnSO_42.5〜50重量ppm及びC
oCl_22.5〜50重量ppmを含有する、請求項
1に記載の株851Rの培地。
(5) 5-10% by weight of soybean powder or 5-20% by weight of soybean milk (calculated as soybean weight) or 5-10% by weight of various pulse cakes, sunflower seed cakes, yeast extract or yeast powder 0.02-0. 5% by weight, CaCO_30.0
5-0.5% by weight, K_2HPO_40.02-0.2
Weight %, MgSO_40.01-0.08 weight %, Na
Cl0.01-0.08% by weight, Na_2MoO_45
-50 ppm by weight, Na_2SeO_31.5-10 ppm by weight, ZnSO_42.5-50 ppm by weight and C
Medium of strain 851R according to claim 1, containing oCl_22.5-50 ppm by weight.
(6)澱粉を含む生材料(サツマイモ、ジャガイモ等)
10〜20重量%又は澱粉を含む乾燥材料(トウモロコ
シ粉末等)1〜10重量%、酵母エキス0.04〜0.
08重量%、CaCO_30.05〜0.5重量%、K
_2HPO_40.05〜0.1重量%、MgSO_4
0.02〜0.04重量%、NaCl0.02〜0.0
4重量%、Na_2MoO_410〜20重量ppm、
Na_2SeO_31.5〜20重量ppm、ZnSO
_45〜20重量ppm及びCoCl_25〜20重量
ppmを含有する、請求項1に記載の株851Rの培地
(6) Raw materials containing starch (sweet potatoes, potatoes, etc.)
10-20% by weight or 1-10% by weight of starch-containing dry materials (such as corn flour), yeast extract 0.04-0.
08% by weight, CaCO_30.05-0.5% by weight, K
_2HPO_40.05-0.1% by weight, MgSO_4
0.02-0.04% by weight, NaCl0.02-0.0
4% by weight, Na_2MoO_410-20 ppm by weight,
Na_2SeO_31.5-20 ppm by weight, ZnSO
Medium of strain 851R according to claim 1, containing _45-20 ppm by weight and CoCl_25-20 ppm by weight.
(7)窒素源を含む培地でマイクロバクテリウム突然変
異株851Rによる発酵により生産される栄養溶液。
(7) Nutrient solution produced by fermentation with Microbacterium mutant strain 851R in a medium containing a nitrogen source.
(8)溶液が老化防止効果、体質改善効果、癌細胞増殖
抑制効果、生物の造血刺激及び改善効果、胃粘膜損傷回
復効果、胃粘膜の急性出血に対する治療作用、肝臓損傷
に対する治療作用並びに産褥体質の回復効果を有するこ
とを特徴とする請求項7に記載の851R栄養溶液。
(8) The solution has an anti-aging effect, a constitutional improving effect, a cancer cell proliferation suppressing effect, an effect of stimulating and improving blood formation in living organisms, an effect of recovering gastric mucosal damage, a therapeutic effect on acute bleeding in the gastric mucosa, a therapeutic effect on liver damage, and a postpartum constitution. 851R nutrient solution according to claim 7, characterized in that it has a restorative effect of.
(9)株851Rの細菌又は851栄養溶液から製造さ
れる一連の製品。
(9) A series of products manufactured from bacteria of strain 851R or from 851 nutrient solution.
JP2183854A 1989-07-11 1990-07-11 Microbacterium mutant strain 851R and method for producing 851 nutrient solution by using the strain Expired - Lifetime JP2613664B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN89104615A CN1023409C (en) 1989-07-11 1989-07-11 Production method of nutrient solution
CN89104615.1 1989-07-11

Publications (2)

Publication Number Publication Date
JPH0349680A true JPH0349680A (en) 1991-03-04
JP2613664B2 JP2613664B2 (en) 1997-05-28

Family

ID=4855628

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2183854A Expired - Lifetime JP2613664B2 (en) 1989-07-11 1990-07-11 Microbacterium mutant strain 851R and method for producing 851 nutrient solution by using the strain

Country Status (5)

Country Link
JP (1) JP2613664B2 (en)
CN (1) CN1023409C (en)
AU (1) AU624690B2 (en)
CA (1) CA2012278C (en)
GB (1) GB2233666B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU218045B (en) 1991-06-03 2000-05-28 Innovi N.V. Process for the production of a selenium-rich additive
CN1101471C (en) * 2000-05-26 2003-02-12 黑龙江省轻工科学研究院 Process for preparing active peptide of soybean protein
US7472891B2 (en) 2006-01-30 2009-01-06 Michael D. Schram Bollard assembly
CN102719369B (en) * 2011-06-14 2013-12-04 广西中烟工业有限责任公司 Microbial strain and application thereof
US20140302171A1 (en) * 2011-10-12 2014-10-09 For Days Co., Ltd Cysteine Peptide-Containing Health Drink

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920052A (en) * 1988-02-05 1990-04-24 Miles Inc. Process for producing glucose isomerase

Also Published As

Publication number Publication date
AU624690B2 (en) 1992-06-18
CN1023409C (en) 1994-01-05
AU5210090A (en) 1991-01-17
GB9010885D0 (en) 1990-07-04
GB2233666B (en) 1993-08-04
JP2613664B2 (en) 1997-05-28
CA2012278A1 (en) 1991-01-11
GB2233666A (en) 1991-01-16
CN1042376A (en) 1990-05-23
CA2012278C (en) 1998-06-02

Similar Documents

Publication Publication Date Title
AU2019204868A1 (en) Production method of high bioactivity whole egg fermentation, and products and applications thereof
CN101696444B (en) Polypeptide extract as well as preparation method and application thereof
CN113355376A (en) Method for synthesizing B vitamins by fermenting bifidobacterium lactis BL-99 and application
CN108913637A (en) A kind of lactobacillus plantarum complexing agent and its preparation method and application
TW202302134A (en) Use of noni fruit ferment in the manufacture of product for improving body shape and improving skin condition
WO2006093267A1 (en) Fermentation composition having immunomodulating effect
CN116925938B (en) Yeast protein powder and preparation method thereof
CN107549817A (en) A kind of natural organic calcium of Moringa and preparation method thereof
CN114128890A (en) Nutritional supplement composition
JP2001149049A (en) Oyster extract having high mineral content and method for producing the same
CN117044935A (en) Nutritional composition formula with uric acid-lowering function and preparation method thereof
JPS60196157A (en) Food containing euglena
JPH0349680A (en) Microbacterium mutation strain 851r and preparation of 851 nutrition solution by application of said strain
CN103416584B (en) Method for improving the quality of broiler meat by using microecological preparations for broiler chickens
CN114651983A (en) A kind of Bacillus coagulans with uric acid-lowering and antioxidant capacity derived from shrimp paste, method and application
CN104593307A (en) Lactobacillus rhamnosus with angiotensinase inhibiting function and application of lactobacillus rhamnosus
CN113355374A (en) Method for synthesizing B vitamins by fermenting lactobacillus paracasei ET-22 and application
CN1536069B (en) Method for large-scale production of catepillar fungus and lucid ganoderma
JP2621100B2 (en) Mutant strain YZH of Pseudomonas and method for producing 851 YZH nutrient solution by applying this strain
CN110679660A (en) A kind of lycium barbarum polysaccharide yogurt for liver protection and hangover and preparation method thereof
CN113999884B (en) Preparation method of turtle bioactive peptide
CN106135427A (en) Lactic acid bacteria, vegetable protein beverage formula
JP3029057B2 (en) Milk composition for food allergy
CN108813250A (en) A kind of Sipunculus nudus fruit-flavored beverage and preparation method thereof containing biodiasmin
CN115299593A (en) Kudzuvine root, hovenia dulcis and roselle enzyme with function of dispelling effects of alcohol and preparation method thereof

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090227

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090227

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100227

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100227

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110227

Year of fee payment: 14

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110227

Year of fee payment: 14